Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 37.08B JPY in the quarter ending June 30, 2026, with 1.85% growth. This brings the company's total for the last twelve months to 167.47B, up 3.71% year-over-year. In the year 2025, Kobayashi Pharmaceutical had annual revenue of 165.74B with 0.09% growth. That makes Kobayashi Pharmaceutical the 7,346th largest company in the world by revenue and 752nd in Japan.

• Revenue (ttm): 167.47B
• Revenue Growth: +3.71%
• P/S Ratio: 3.21
• Revenue / Employee: 44.89M
• Employees: 3,731
• Market Cap: 538.21B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Domestic Business (Incl. Mail Order Business) 122.92B 69.1%
• International Business 48.42B 27.2%
• Others 6.58B 3.7%

By Geography

Chart

• Japan 118.75B 71.6%
• USA 23.81B 14.4%
• China 9.61B 5.8%
• Southeast Asia 9.30B 5.6%
• Others 4.27B 2.6%

Fiscal year ended Dec 31, 2025 See the full Kobayashi Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	165.74B	142.00M	0.09%
Dec 31, 2024	165.60B	-7.86B	-4.53%
Dec 31, 2023	173.46B	7.20B	4.33%
Dec 31, 2022	166.26B	11.01B	7.09%
Dec 31, 2021	155.25B	4.74B	3.15%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error